Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Picked some more shares this morning

<< Previous

Bullboard Posts

Next >>

Post by CMHarring218431on Dec 28, 2023 10:09am

264 Views

Post# 35802495

Picked some more shares this morning

Figured we had to get at least some impetus because of January effect and no more tax loss selling. Although, one more day on Nasdeq. Not a day trader at all but it is a no brainer to me for relatively short period of time to pick something.I'm thinking a nice little bump thru next week

<< Previous

Bullboard Posts

Next >>

Optimi Health makes commercial entry into Australia